Clinical Trial Update: Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial DERAIL-LVV is evaluating the combination of dapagliflozin with endothelin receptor antagonism for large vessel vasculitis, including gian…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Arteritis
• Takayasu Arteritis

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Endothelin receptor antagonist (investigational)

Snippet

Sponsor: University of Edinburgh | Conditions: Large Vessel Vasculitis, Giant Cell Arteritis (GCA) | Phase 2 | Status: RECRUITING